APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Release Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Release Platform Market Analysis and Forecast 2026-2032

16 April 2026214 pages

Choose your research edition.

Industry ResearchDrug Release Platform Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Release Platform Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Drug Release Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Release Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Drug Release Platform Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Drug Release Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Release Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Release Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Release Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Release Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Release Platform include Evonik, Camurus, Pacira BioSciences, Starpharma, ProLynx, Liquidia, MedinCell, Intarcia and Corium, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Release Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Release Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Release Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Release Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Release Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Release Platform revenue, projected growth trends, production technology, application and end-user industry.

Drug Release Platform Segment by Company

Evonik

Camurus

Pacira BioSciences

Starpharma

ProLynx

Liquidia

MedinCell

Intarcia

Corium

Enable Injections

Alkermes

Depomed

NanoCarrier

Lyndra

Hisun Pharmaceutical

Livzon Pharmaceutical Group

Hengrui Pharmaceuticals

HEC ChangJiang Pharmaceutical

Luye Pharma

Lanna Bio

Drug Release Platform Segment by Type

Oral Sustained-Release Platform

Implantable Sustained-Release Platform

Local Sustained-Release Platform

Drug Release Platform Segment by Application

Pharmaceutical Companies

Hospitals

Others

Drug Release Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Release Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Release Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Release Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Release Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Release Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Release Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Release Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Sustained-Release Platform Major Player Table 3. Implantable Sustained-Release Platform Major Player Table 4. Local Sustained-Release Platform Major Player Table 5. Global Drug Release Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Companies Major Player Table 7. Hospitals Major Player Table 8. Others Major Player Table 9. Drug Release Platform Industry Trends Table 10. Drug Release Platform Industry Drivers Table 11. Drug Release Platform Industry Opportunities and Challenges Table 12. Drug Release Platform Industry Restraints Table 13. Global Drug Release Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Drug Release Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Drug Release Platform Market Share by Region (2021-2026) Table 16. Global Drug Release Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Drug Release Platform Market Share by Region (2027-2032) Table 18. Global Drug Release Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Drug Release Platform Revenue Market Share by Players (2021-2026) Table 20. Global Drug Release Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug Release Platform Key Players Headquarters & Area Served Table 22. Global Drug Release Platform Players, Product Type & Application Table 23. Global Drug Release Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug Release Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Drug Release Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Drug Release Platform Revenue Market Share by Type (2021-2026) Table 30. Global Drug Release Platform Revenue Market Share by Type (2027-2032) Table 31. Global Drug Release Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Drug Release Platform Revenue Market Share by Application (2021-2026) Table 35. Global Drug Release Platform Revenue Market Share by Application (2027-2032) Table 36. Evonik Company Information Table 37. Evonik Business Overview Table 38. Evonik Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Evonik Drug Release Platform Product Portfolio Table 40. Evonik Recent Development Table 41. Camurus Company Information Table 42. Camurus Business Overview Table 43. Camurus Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Camurus Drug Release Platform Product Portfolio Table 45. Camurus Recent Development Table 46. Pacira BioSciences Company Information Table 47. Pacira BioSciences Business Overview Table 48. Pacira BioSciences Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pacira BioSciences Drug Release Platform Product Portfolio Table 50. Pacira BioSciences Recent Development Table 51. Starpharma Company Information Table 52. Starpharma Business Overview Table 53. Starpharma Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Starpharma Drug Release Platform Product Portfolio Table 55. Starpharma Recent Development Table 56. ProLynx Company Information Table 57. ProLynx Business Overview Table 58. ProLynx Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ProLynx Drug Release Platform Product Portfolio Table 60. ProLynx Recent Development Table 61. Liquidia Company Information Table 62. Liquidia Business Overview Table 63. Liquidia Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Liquidia Drug Release Platform Product Portfolio Table 65. Liquidia Recent Development Table 66. MedinCell Company Information Table 67. MedinCell Business Overview Table 68. MedinCell Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. MedinCell Drug Release Platform Product Portfolio Table 70. MedinCell Recent Development Table 71. Intarcia Company Information Table 72. Intarcia Business Overview Table 73. Intarcia Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Intarcia Drug Release Platform Product Portfolio Table 75. Intarcia Recent Development Table 76. Corium Company Information Table 77. Corium Business Overview Table 78. Corium Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Corium Drug Release Platform Product Portfolio Table 80. Corium Recent Development Table 81. Enable Injections Company Information Table 82. Enable Injections Business Overview Table 83. Enable Injections Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Enable Injections Drug Release Platform Product Portfolio Table 85. Enable Injections Recent Development Table 86. Alkermes Company Information Table 87. Alkermes Business Overview Table 88. Alkermes Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Alkermes Drug Release Platform Product Portfolio Table 90. Alkermes Recent Development Table 91. Depomed Company Information Table 92. Depomed Business Overview Table 93. Depomed Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Depomed Drug Release Platform Product Portfolio Table 95. Depomed Recent Development Table 96. NanoCarrier Company Information Table 97. NanoCarrier Business Overview Table 98. NanoCarrier Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. NanoCarrier Drug Release Platform Product Portfolio Table 100. NanoCarrier Recent Development Table 101. Lyndra Company Information Table 102. Lyndra Business Overview Table 103. Lyndra Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Lyndra Drug Release Platform Product Portfolio Table 105. Lyndra Recent Development Table 106. Hisun Pharmaceutical Company Information Table 107. Hisun Pharmaceutical Business Overview Table 108. Hisun Pharmaceutical Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Hisun Pharmaceutical Drug Release Platform Product Portfolio Table 110. Hisun Pharmaceutical Recent Development Table 111. Livzon Pharmaceutical Group Company Information Table 112. Livzon Pharmaceutical Group Business Overview Table 113. Livzon Pharmaceutical Group Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Livzon Pharmaceutical Group Drug Release Platform Product Portfolio Table 115. Livzon Pharmaceutical Group Recent Development Table 116. Hengrui Pharmaceuticals Company Information Table 117. Hengrui Pharmaceuticals Business Overview Table 118. Hengrui Pharmaceuticals Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Hengrui Pharmaceuticals Drug Release Platform Product Portfolio Table 120. Hengrui Pharmaceuticals Recent Development Table 121. HEC ChangJiang Pharmaceutical Company Information Table 122. HEC ChangJiang Pharmaceutical Business Overview Table 123. HEC ChangJiang Pharmaceutical Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. HEC ChangJiang Pharmaceutical Drug Release Platform Product Portfolio Table 125. HEC ChangJiang Pharmaceutical Recent Development Table 126. Luye Pharma Company Information Table 127. Luye Pharma Business Overview Table 128. Luye Pharma Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Luye Pharma Drug Release Platform Product Portfolio Table 130. Luye Pharma Recent Development Table 131. Lanna Bio Company Information Table 132. Lanna Bio Business Overview Table 133. Lanna Bio Drug Release Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Lanna Bio Drug Release Platform Product Portfolio Table 135. Lanna Bio Recent Development Table 136. North America Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Drug Release Platform Revenue by Country (2021-2026) & (US$ Million) Table 142. North America Drug Release Platform Revenue by Country (US$ Million) & (2027-2032) Table 143. Europe Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Drug Release Platform Revenue by Country (2021-2026) & (US$ Million) Table 149. Europe Drug Release Platform Revenue by Country (US$ Million) & (2027-2032) Table 150. China Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 151. China Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 152. China Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 153. China Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Drug Release Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Drug Release Platform Revenue by Region (US$ Million) & (2021-2026) Table 160. Asia Drug Release Platform Revenue by Region (US$ Million) & (2027-2032) Table 161. SAMEA Drug Release Platform Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Drug Release Platform Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Drug Release Platform Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Drug Release Platform Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Drug Release Platform Revenue by Country (2021-2026) & (US$ Million) Table 167. SAMEA Drug Release Platform Revenue by Country (US$ Million) & (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Drug Release Platform Image Figure 2. Global Drug Release Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Release Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Sustained-Release Platform Image Figure 5. Implantable Sustained-Release Platform Image Figure 6. Local Sustained-Release Platform Image Figure 7. Global Drug Release Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Release Platform Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Companies Image Figure 10. Hospitals Image Figure 11. Others Image Figure 12. Global Drug Release Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global Drug Release Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Drug Release Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Drug Release Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Drug Release Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug Release Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Drug Release Platform Revenue Market Share by Type (2021-2032) Figure 20. Global Drug Release Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Release Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Drug Release Platform Revenue Market Share by Application (2021-2032) Figure 23. North America Drug Release Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Drug Release Platform Revenue Share by Type (2021-2032) Figure 25. North America Drug Release Platform Revenue Share by Application (2021-2032) Figure 26. North America Drug Release Platform Revenue Share by Country (2021-2032) Figure 27. United States Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Drug Release Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Drug Release Platform Revenue Share by Type (2021-2032) Figure 32. Europe Drug Release Platform Revenue Share by Application (2021-2032) Figure 33. Europe Drug Release Platform Revenue Share by Country (2021-2032) Figure 34. Germany Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Drug Release Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Drug Release Platform Revenue Share by Type (2021-2032) Figure 44. China Drug Release Platform Revenue Share by Application (2021-2032) Figure 45. Asia Drug Release Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Drug Release Platform Revenue Share by Type (2021-2032) Figure 47. Asia Drug Release Platform Revenue Share by Application (2021-2032) Figure 48. Asia Drug Release Platform Revenue Share by Region (2021-2032) Figure 49. Japan Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Drug Release Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Drug Release Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA Drug Release Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA Drug Release Platform Revenue Share by Country (2021-2032) Figure 59. Brazil Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Drug Release Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Sustained-Release Platform
  • Implantable Sustained-Release Platform
  • Local Sustained-Release Platform
Applications
  • Pharmaceutical Companies
  • Hospitals
  • Others
Companies covered
  • Evonik
  • Camurus
  • Pacira BioSciences
  • Starpharma
  • ProLynx
  • Liquidia
  • MedinCell
  • Intarcia
  • Corium
  • Enable Injections
  • Alkermes
  • Depomed
  • NanoCarrier
  • Lyndra
  • Hisun Pharmaceutical
  • Livzon Pharmaceutical Group
  • Hengrui Pharmaceuticals
  • HEC ChangJiang Pharmaceutical
  • Luye Pharma
  • Lanna Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Release Platform Market by Type
  3. 1.2.1 Global Drug Release Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Sustained-Release Platform
  5. 1.2.3 Implantable Sustained-Release Platform
  6. 1.2.4 Local Sustained-Release Platform
  7. 1.3 Drug Release Platform Market by Application
  8. 1.3.1 Global Drug Release Platform Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Companies
  10. 1.3.3 Hospitals
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Drug Release Platform Market Dynamics
  1. 2.1 Drug Release Platform Industry Trends
  2. 2.2 Drug Release Platform Industry Drivers
  3. 2.3 Drug Release Platform Industry Opportunities and Challenges
  4. 2.4 Drug Release Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Release Platform Market Perspective (2021-2032)
  2. 3.2 Global Drug Release Platform Growth Trends by Region
  3. 3.2.1 Global Drug Release Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Release Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Release Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Release Platform Revenue by Players
  2. 4.1.1 Global Drug Release Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Release Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Release Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Release Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Release Platform Key Players Headquarters & Area Served
  7. 4.4 Global Drug Release Platform Players, Product Type & Application
  8. 4.5 Global Drug Release Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Release Platform Market CR5 and HHI
  11. 4.6.3 2025 Drug Release Platform Tier 1, Tier 2, and Tier 3
5 Drug Release Platform Market Size by Type
  1. 5.1 Global Drug Release Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Release Platform Revenue by Type (2021-2032)
  3. 5.3 Global Drug Release Platform Revenue Market Share by Type (2021-2032)
6 Drug Release Platform Market Size by Application
  1. 6.1 Global Drug Release Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Release Platform Revenue by Application (2021-2032)
  3. 6.3 Global Drug Release Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Evonik
  2. 7.1.1 Evonik Company Information
  3. 7.1.2 Evonik Business Overview
  4. 7.1.3 Evonik Drug Release Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Evonik Drug Release Platform Product Portfolio
  6. 7.1.5 Evonik Recent Developments
  7. 7.2 Camurus
  8. 7.2.1 Camurus Company Information
  9. 7.2.2 Camurus Business Overview
  10. 7.2.3 Camurus Drug Release Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Camurus Drug Release Platform Product Portfolio
  12. 7.2.5 Camurus Recent Developments
  13. 7.3 Pacira BioSciences
  14. 7.3.1 Pacira BioSciences Company Information
  15. 7.3.2 Pacira BioSciences Business Overview
  16. 7.3.3 Pacira BioSciences Drug Release Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pacira BioSciences Drug Release Platform Product Portfolio
  18. 7.3.5 Pacira BioSciences Recent Developments
  19. 7.4 Starpharma
  20. 7.4.1 Starpharma Company Information
  21. 7.4.2 Starpharma Business Overview
  22. 7.4.3 Starpharma Drug Release Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Starpharma Drug Release Platform Product Portfolio
  24. 7.4.5 Starpharma Recent Developments
  25. 7.5 ProLynx
  26. 7.5.1 ProLynx Company Information
  27. 7.5.2 ProLynx Business Overview
  28. 7.5.3 ProLynx Drug Release Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ProLynx Drug Release Platform Product Portfolio
  30. 7.5.5 ProLynx Recent Developments
  31. 7.6 Liquidia
  32. 7.6.1 Liquidia Company Information
  33. 7.6.2 Liquidia Business Overview
  34. 7.6.3 Liquidia Drug Release Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Liquidia Drug Release Platform Product Portfolio
  36. 7.6.5 Liquidia Recent Developments
  37. 7.7 MedinCell
  38. 7.7.1 MedinCell Company Information
  39. 7.7.2 MedinCell Business Overview
  40. 7.7.3 MedinCell Drug Release Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MedinCell Drug Release Platform Product Portfolio
  42. 7.7.5 MedinCell Recent Developments
  43. 7.8 Intarcia
  44. 7.8.1 Intarcia Company Information
  45. 7.8.2 Intarcia Business Overview
  46. 7.8.3 Intarcia Drug Release Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Intarcia Drug Release Platform Product Portfolio
  48. 7.8.5 Intarcia Recent Developments
  49. 7.9 Corium
  50. 7.9.1 Corium Company Information
  51. 7.9.2 Corium Business Overview
  52. 7.9.3 Corium Drug Release Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Corium Drug Release Platform Product Portfolio
  54. 7.9.5 Corium Recent Developments
  55. 7.10 Enable Injections
  56. 7.10.1 Enable Injections Company Information
  57. 7.10.2 Enable Injections Business Overview
  58. 7.10.3 Enable Injections Drug Release Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Enable Injections Drug Release Platform Product Portfolio
  60. 7.10.5 Enable Injections Recent Developments
  61. 7.11 Alkermes
  62. 7.11.1 Alkermes Company Information
  63. 7.11.2 Alkermes Business Overview
  64. 7.11.3 Alkermes Drug Release Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Alkermes Drug Release Platform Product Portfolio
  66. 7.11.5 Alkermes Recent Developments
  67. 7.12 Depomed
  68. 7.12.1 Depomed Company Information
  69. 7.12.2 Depomed Business Overview
  70. 7.12.3 Depomed Drug Release Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Depomed Drug Release Platform Product Portfolio
  72. 7.12.5 Depomed Recent Developments
  73. 7.13 NanoCarrier
  74. 7.13.1 NanoCarrier Company Information
  75. 7.13.2 NanoCarrier Business Overview
  76. 7.13.3 NanoCarrier Drug Release Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 NanoCarrier Drug Release Platform Product Portfolio
  78. 7.13.5 NanoCarrier Recent Developments
  79. 7.14 Lyndra
  80. 7.14.1 Lyndra Company Information
  81. 7.14.2 Lyndra Business Overview
  82. 7.14.3 Lyndra Drug Release Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Lyndra Drug Release Platform Product Portfolio
  84. 7.14.5 Lyndra Recent Developments
  85. 7.15 Hisun Pharmaceutical
  86. 7.15.1 Hisun Pharmaceutical Company Information
  87. 7.15.2 Hisun Pharmaceutical Business Overview
  88. 7.15.3 Hisun Pharmaceutical Drug Release Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Hisun Pharmaceutical Drug Release Platform Product Portfolio
  90. 7.15.5 Hisun Pharmaceutical Recent Developments
  91. 7.16 Livzon Pharmaceutical Group
  92. 7.16.1 Livzon Pharmaceutical Group Company Information
  93. 7.16.2 Livzon Pharmaceutical Group Business Overview
  94. 7.16.3 Livzon Pharmaceutical Group Drug Release Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Livzon Pharmaceutical Group Drug Release Platform Product Portfolio
  96. 7.16.5 Livzon Pharmaceutical Group Recent Developments
  97. 7.17 Hengrui Pharmaceuticals
  98. 7.17.1 Hengrui Pharmaceuticals Company Information
  99. 7.17.2 Hengrui Pharmaceuticals Business Overview
  100. 7.17.3 Hengrui Pharmaceuticals Drug Release Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Hengrui Pharmaceuticals Drug Release Platform Product Portfolio
  102. 7.17.5 Hengrui Pharmaceuticals Recent Developments
  103. 7.18 HEC ChangJiang Pharmaceutical
  104. 7.18.1 HEC ChangJiang Pharmaceutical Company Information
  105. 7.18.2 HEC ChangJiang Pharmaceutical Business Overview
  106. 7.18.3 HEC ChangJiang Pharmaceutical Drug Release Platform Revenue and Gross Margin (2021-2026)
  107. 7.18.4 HEC ChangJiang Pharmaceutical Drug Release Platform Product Portfolio
  108. 7.18.5 HEC ChangJiang Pharmaceutical Recent Developments
  109. 7.19 Luye Pharma
  110. 7.19.1 Luye Pharma Company Information
  111. 7.19.2 Luye Pharma Business Overview
  112. 7.19.3 Luye Pharma Drug Release Platform Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Luye Pharma Drug Release Platform Product Portfolio
  114. 7.19.5 Luye Pharma Recent Developments
  115. 7.20 Lanna Bio
  116. 7.20.1 Lanna Bio Company Information
  117. 7.20.2 Lanna Bio Business Overview
  118. 7.20.3 Lanna Bio Drug Release Platform Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Lanna Bio Drug Release Platform Product Portfolio
  120. 7.20.5 Lanna Bio Recent Developments
8 North America
  1. 8.1 North America Drug Release Platform Revenue (2021-2032)
  2. 8.2 North America Drug Release Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Release Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Release Platform Revenue by Type (2027-2032)
  5. 8.3 North America Drug Release Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Release Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Release Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Release Platform Revenue by Application (2027-2032)
  9. 8.5 North America Drug Release Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Release Platform Revenue by Country
  11. 8.6.1 North America Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Release Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Release Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Release Platform Revenue (2021-2032)
  2. 9.2 Europe Drug Release Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Release Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Release Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Release Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Release Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Release Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Release Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Release Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Release Platform Revenue by Country
  11. 9.6.1 Europe Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Release Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Release Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Release Platform Revenue (2021-2032)
  2. 10.2 China Drug Release Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Release Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Release Platform Revenue by Type (2027-2032)
  5. 10.3 China Drug Release Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Release Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Release Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Release Platform Revenue by Application (2027-2032)
  9. 10.5 China Drug Release Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Release Platform Revenue (2021-2032)
  2. 11.2 Asia Drug Release Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Release Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Release Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Release Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Release Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Release Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Release Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Release Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Release Platform Revenue by Country
  11. 11.6.1 Asia Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Release Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Release Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Release Platform Revenue (2021-2032)
  2. 12.2 SAMEA Drug Release Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Release Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Release Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Release Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Release Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Release Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Release Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Release Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Release Platform Revenue by Country
  11. 12.6.1 SAMEA Drug Release Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Release Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Release Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst